• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药治疗患者的口腔表现:一项系统评价。

Oral Manifestations in Patients in Treatment with Antidepressants: A Systematic Review.

作者信息

Alcázar-Hernández Juan Manuel, Pecci-Lloret Miguel Ramón, Guerrero-Gironés Julia

机构信息

Gerodontologý an Special Care Dentistry Unit, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30008 Murcia, Spain.

出版信息

J Clin Med. 2024 Nov 18;13(22):6945. doi: 10.3390/jcm13226945.

DOI:10.3390/jcm13226945
PMID:39598089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11594724/
Abstract

: The rising use of antidepressants is linked to oral health risks, including xerostomia, caries, and periodontal disease. Recognizing these risks is essential for improving patient care. To systematically review oral manifestations in patients undergoing antidepressant treatment. : This review follows the PRISMA guidelines and includes observational studies published in the last 21 years. A PICO-based question was developed to select relevant studies, which were assessed for quality using a modified STROBE checklist. : A total of 11 studies were analyzed, revealing a consistent association between antidepressant use and the increased risk of xerostomia, caries, and periodontal disease. Additional findings included taste dysfunction and oral bleeding complications. Among the antidepressants, selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) were most commonly associated with xerostomia and caries. However, no significant impact was observed on the chemical composition of saliva or on hemostasis in invasive dental procedures. : Antidepressant use may lead to significant oral health issues, notably xerostomia and caries. Further studies are recommended to clarify the influence of specific antidepressants and confounding factors, such as treatment duration, dosage, and hygiene habits, on oral health outcomes.

摘要

抗抑郁药使用的增加与口腔健康风险相关,包括口干、龋齿和牙周疾病。认识到这些风险对于改善患者护理至关重要。旨在系统回顾接受抗抑郁药治疗患者的口腔表现。

本综述遵循PRISMA指南,纳入过去21年发表的观察性研究。制定了基于PICO的问题以选择相关研究,并使用改良的STROBE清单评估研究质量。

共分析了11项研究,结果显示抗抑郁药的使用与口干、龋齿和牙周疾病风险增加之间存在一致关联。其他发现包括味觉功能障碍和口腔出血并发症。在抗抑郁药中,选择性5-羟色胺再摄取抑制剂(SSRIs)和三环类抗抑郁药(TCAs)与口干和龋齿最为相关。然而,未观察到对唾液化学成分或侵入性牙科手术中的止血有显著影响。

使用抗抑郁药可能导致严重的口腔健康问题,尤其是口干和龋齿。建议进一步研究以阐明特定抗抑郁药和混杂因素(如治疗持续时间、剂量和卫生习惯)对口腔健康结果的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/5c5a4d51e97e/jcm-13-06945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/ff99c1b1e017/jcm-13-06945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/838950c87d98/jcm-13-06945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/db92167f366d/jcm-13-06945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/5c5a4d51e97e/jcm-13-06945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/ff99c1b1e017/jcm-13-06945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/838950c87d98/jcm-13-06945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/db92167f366d/jcm-13-06945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f227/11594724/5c5a4d51e97e/jcm-13-06945-g004.jpg

相似文献

1
Oral Manifestations in Patients in Treatment with Antidepressants: A Systematic Review.抗抑郁药治疗患者的口腔表现:一项系统评价。
J Clin Med. 2024 Nov 18;13(22):6945. doi: 10.3390/jcm13226945.
2
Antidepressant use and risk of adverse outcomes in older people: population based cohort study.抗抑郁药的使用与老年人不良结局风险:基于人群的队列研究。
BMJ. 2011 Aug 2;343:d4551. doi: 10.1136/bmj.d4551.
3
Does the use of SSRIs reduce medical care utilization and expenditures?使用选择性5-羟色胺再摄取抑制剂(SSRI)是否会降低医疗服务利用率和支出?
J Ment Health Policy Econ. 2005 Sep;8(3):119-29.
4
Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.与遵循美国国家质量保证委员会(NCQA)医疗效果数据和信息集(HEDIS)抗抑郁药物管理措施相关的更高成本和治疗因素:行政索赔分析
J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54. doi: 10.18553/jmcp.2006.12.1.43.
5
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.一项关于老年人抗抑郁药安全性和危害的研究:一项使用大型初级保健数据库的队列研究。
Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv. doi: 10.3310/hta15280.
6
Pharmacological interventions for somatoform disorders in adults.成人躯体形式障碍的药物干预
Cochrane Database Syst Rev. 2014 Nov 7;2014(11):CD010628. doi: 10.1002/14651858.CD010628.pub2.
7
Antidepressants plus benzodiazepines for adults with major depression.抗抑郁药加苯二氮䓬类药物用于治疗重度抑郁症的成年人。
Cochrane Database Syst Rev. 2019 Jun 3;6(6):CD001026. doi: 10.1002/14651858.CD001026.pub2.
8
Antidepressants for low back pain and spine-related leg pain.用于治疗腰痛和脊柱相关性腿痛的抗抑郁药。
Cochrane Database Syst Rev. 2025 Mar 10;3(3):CD001703. doi: 10.1002/14651858.CD001703.pub4.
9
Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patients.帕金森病(PD)患者抗抑郁治疗中选择性5-羟色胺再摄取抑制剂(SSRIs)与三环类抗抑郁药(TCAs)疗效及安全性比较的Meta分析
Iran J Pharm Res. 2014 Fall;13(4):1213-9.
10
Pharmacological treatments in panic disorder in adults: a network meta-analysis.成人惊恐障碍的药物治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.

引用本文的文献

1
Association between selective serotonin reuptake inhibitors and the periodontal status: a systematic review and meta-analysis of observational clinical studies.选择性5-羟色胺再摄取抑制剂与牙周状况之间的关联:观察性临床研究的系统评价和荟萃分析
Evid Based Dent. 2025 Jul 22. doi: 10.1038/s41432-025-01179-8.